An orally available tubulin inhibitor, VERU-111, to overcome paclitaxel resistance and to suppress breast cancer tumor growth and metastasis.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e13110-e13110
Author(s):  
Shanshan Deng ◽  
Raisa I Krutilina ◽  
Qinghui Wang ◽  
Tiffany N. Seagroves ◽  
Duane D. Miller ◽  
...  
Cell Cycle ◽  
2012 ◽  
Vol 11 (21) ◽  
pp. 3972-3982 ◽  
Author(s):  
Gloria Bonuccelli ◽  
Remedios Castello-Cros ◽  
Franco Capozza ◽  
Ubaldo E. Martinez-Outschoorn ◽  
Zhao Lin ◽  
...  

2019 ◽  
Vol 145 (10) ◽  
pp. 2767-2780 ◽  
Author(s):  
Zhishan Wang ◽  
Yunfei Li ◽  
Yajuan Xiao ◽  
Hsuan‐Pei Lin ◽  
Ping Yang ◽  
...  

2013 ◽  
Author(s):  
Erik Russell Nelson ◽  
Suzanne E. Wardell ◽  
Matthew K. Howe ◽  
Nicole J. Carver ◽  
Michihisa Umetani ◽  
...  

2010 ◽  
Vol 8 (7) ◽  
pp. 60
Author(s):  
M.A. Hallett ◽  
B. Teng ◽  
T. Seagroves ◽  
T. Sweatman ◽  
T. Pourmotabbed

2016 ◽  
Vol 28 (2) ◽  
pp. 461-470 ◽  
Author(s):  
Lindsay E. Calderon ◽  
Jonathan K. Keeling ◽  
Joseph Rollins ◽  
Carrie A. Black ◽  
Kendall Collins ◽  
...  

Oncogene ◽  
2015 ◽  
Vol 35 (25) ◽  
pp. 3314-3323 ◽  
Author(s):  
J Du ◽  
M Yang ◽  
S Chen ◽  
D Li ◽  
Z Chang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document